| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |